Jazz Pharma's decision to revoke U.S. patent for rival narcolepsy drug

Published Date: 02 Mar 2023

A U.S. court on Friday ordered Jazz Pharmaceuticals to revoke its patents related to its flagship narcolepsy drug Xyrem from the FDA-approved brand name drug after winning a case against Avadel foe CNS Pharmaceuticals.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Decoding calcifications in breast cancer: Towards personalized medicine

2.

Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC

3.

Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer.

4.

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

5.

Researchers study effects of cannabis on sedation, cancer treatment symptoms


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot